Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome

Christiane Querfeld*, Steven T. Rosen, Joan Guitart, Madeleine Duvic, Youn H. Kim, Stephen W. Dusza, Timothy M. Kuzel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds